NAS:MLTX (Switzerland)
Â
Class A
$
20
+0.10 (+0.53%)
12:58 PM EST
MoonLake Immunotherapeutics Valuation Measures
Fundamental (50)
Valuation Ratio (87)
Profitability (8)
Price (22)
Dividends (7)
Income Statement (47)
Balance Sheet (85)
Cashflow statement (66)